Brief: Adage Capital Management Reports 8.28% Stake In Arca Biopharma - SEC Filing
05/04/2024 22:40
April 5 (Reuters) - ARCA Biopharma Inc ABIO.O :
* ADAGE CAPITAL MANAGEMENT, L.P. REPORTS 8.28% STAKE IN ARCA
BIOPHARMA AS OF APRIL 3- SEC FILING
Source text for Eikon: ID:n0000902664-24-002769
Further company coverage: ABIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oruka Therapeutics
See all newsOruka falls after reporting mid-stage data for psoriasis drug
Brief: Oruka Therapeutics Announces Positive Week 28 Data For Orka-001 From The Ongoing Everlast-A Trial Showing Deepening Of Responses Without Additional Dosing
Brief: Oruka Therapeutics Appoints Todd Edwards As Chief Commercial Officer
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
Oruka Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary